GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Acquired by Gladstone Institutional Advisory LLC

Gladstone Institutional Advisory LLC boosted its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 27.6% during the fourth quarter, Holdings Channel.com reports. The fund owned 3,938 shares of the company’s stock after purchasing an additional 851 shares during the quarter. Gladstone Institutional Advisory LLC’s holdings in GE HealthCare Technologies were worth $304,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. Jennison Associates LLC grew its stake in GE HealthCare Technologies by 49.4% in the 4th quarter. Jennison Associates LLC now owns 1,208,830 shares of the company’s stock valued at $93,467,000 after acquiring an additional 399,961 shares during the period. South Dakota Investment Council lifted its holdings in GE HealthCare Technologies by 272.1% in the 4th quarter. South Dakota Investment Council now owns 98,262 shares of the company’s stock valued at $7,598,000 after purchasing an additional 71,857 shares in the last quarter. Cerity Partners LLC lifted its holdings in GE HealthCare Technologies by 27.2% in the 4th quarter. Cerity Partners LLC now owns 45,929 shares of the company’s stock valued at $3,551,000 after purchasing an additional 9,809 shares in the last quarter. Fifth Third Bancorp lifted its holdings in GE HealthCare Technologies by 3.9% in the 4th quarter. Fifth Third Bancorp now owns 33,632 shares of the company’s stock valued at $2,600,000 after purchasing an additional 1,250 shares in the last quarter. Finally, Douglas Lane & Associates LLC lifted its holdings in GE HealthCare Technologies by 22.1% in the 4th quarter. Douglas Lane & Associates LLC now owns 436,253 shares of the company’s stock valued at $33,731,000 after purchasing an additional 79,073 shares in the last quarter. Institutional investors and hedge funds own 82.06% of the company’s stock.

Insider Activity

In other news, insider Frank R. Jimenez acquired 1,315 shares of GE HealthCare Technologies stock in a transaction dated Wednesday, May 1st. The shares were acquired at an average cost of $76.52 per share, with a total value of $100,623.80. Following the purchase, the insider now directly owns 75,796 shares of the company’s stock, valued at approximately $5,799,909.92. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. In related news, insider Frank R. Jimenez purchased 1,315 shares of GE HealthCare Technologies stock in a transaction that occurred on Wednesday, May 1st. The shares were purchased at an average cost of $76.52 per share, with a total value of $100,623.80. Following the transaction, the insider now owns 75,796 shares of the company’s stock, valued at approximately $5,799,909.92. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Jan Makela sold 20,227 shares of the business’s stock in a transaction that occurred on Monday, May 13th. The stock was sold at an average price of $81.57, for a total value of $1,649,916.39. Following the transaction, the chief executive officer now directly owns 63,348 shares in the company, valued at $5,167,296.36. The disclosure for this sale can be found here. Corporate insiders own 0.27% of the company’s stock.

GE HealthCare Technologies Trading Down 1.6 %

Shares of GEHC stock opened at $79.33 on Friday. GE HealthCare Technologies Inc. has a fifty-two week low of $62.35 and a fifty-two week high of $94.50. The stock has a market cap of $36.21 billion, a P/E ratio of 23.20, a P/E/G ratio of 2.90 and a beta of 1.26. The business has a fifty day simple moving average of $85.31 and a 200-day simple moving average of $80.41. The company has a quick ratio of 0.83, a current ratio of 1.06 and a debt-to-equity ratio of 1.11.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Tuesday, April 30th. The company reported $0.90 EPS for the quarter, hitting analysts’ consensus estimates of $0.90. The firm had revenue of $4.65 billion during the quarter, compared to analysts’ expectations of $4.80 billion. GE HealthCare Technologies had a return on equity of 25.32% and a net margin of 8.05%. The firm’s quarterly revenue was down 1.2% compared to the same quarter last year. During the same quarter last year, the business posted $0.85 EPS. On average, analysts forecast that GE HealthCare Technologies Inc. will post 4.27 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, May 15th. Stockholders of record on Friday, April 19th were paid a $0.03 dividend. This represents a $0.12 annualized dividend and a dividend yield of 0.15%. The ex-dividend date of this dividend was Thursday, April 18th. GE HealthCare Technologies’s dividend payout ratio is currently 3.51%.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on GEHC shares. UBS Group upgraded GE HealthCare Technologies from a “sell” rating to a “neutral” rating and raised their price objective for the company from $66.00 to $88.00 in a report on Monday, February 12th. Argus boosted their price target on shares of GE HealthCare Technologies from $80.00 to $110.00 and gave the company a “buy” rating in a research report on Monday, April 1st. Evercore ISI boosted their price target on shares of GE HealthCare Technologies from $93.00 to $100.00 and gave the company an “outperform” rating in a research report on Thursday, April 4th. Morgan Stanley boosted their price target on shares of GE HealthCare Technologies from $74.00 to $86.00 and gave the company an “equal weight” rating in a research report on Monday, February 12th. Finally, Mizuho decreased their target price on shares of GE HealthCare Technologies from $110.00 to $105.00 and set a “buy” rating on the stock in a research report on Wednesday, May 1st. Four research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $94.80.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.